TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane.

Peter A Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.